New therapeutic targets for mood disorders - Wikidata - wikimedia - TriplyDB

New therapeutic targets for mood disorders

New therapeutic targets for mood disorders

http://www.wikidata.org/entity/Q28743068

about

Adjunctive antioxidants for bipolar disorder Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.Pharmacological management of binge eating disorder: current and emerging treatment options.A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania.Behavioral and pharmacological assessment of a potential new mouse model for mania Evidence demonstrating role of microRNAs in the etiopathology of major depression Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine.Translational Research in Bipolar Disorders.Circulating microRNA-144-5p is associated with depressive disorders.Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level Evaluation of antidepressant activity of vanillin in mice Emerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications.Novel routes to bipolar disorder drug discovery.The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.Tamoxifen use for the management of mania: a review of current preclinical evidence.Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior?Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress.GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity.Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis

P2860

Q24198987-009507BA-3252-44FF-A8AD-94042F162D91 Q28476686-C8990C4C-6452-42E1-9054-E35D8A6992A0 Q30393882-56E7F18B-82E4-48CD-B97C-B078E7C330B4 Q34278450-3414DC5A-72BF-430D-99CB-1F6EF8A5CBC2 Q34649372-DE7C0BD6-30E2-4C47-91BB-2CCAB721CBE0 Q34850726-92CBB2DE-6DEF-43D3-A367-E429837FDF27 Q35186527-664A9FB5-B56C-4DAB-9AC9-D0F2D7E37A61 Q35353085-88F2F3BF-F8B4-4F13-9E29-8FD0D5E0E747 Q35668022-DDB0E8FC-3408-4238-B362-3DA5366E0C2D Q35871861-168276CA-4C39-4CE5-8584-E5EF446F5BF6 Q36223676-EFAADC27-F180-44A3-94F8-FCDEE12AD897 Q36865440-1DAB6A14-E114-408D-87CD-781D5B1318F1 Q37699995-A3F2AB48-0540-4482-BC8C-7588ADE9D9D5 Q38109244-8AF0969C-6891-4798-9FE7-1000EC70C469 Q38161385-9674836C-3411-4C79-BF3A-BF8F9751FECF Q38179926-5B101405-5881-446B-917F-FA534F6EDAAD Q42015236-7D9418BF-0C1B-48D9-A717-88A57C6CF15A Q42270340-C87408DB-8639-4B80-BA57-478DC5DD03FE Q45949305-6C5B36A8-00F5-4991-94A4-BD37FFB6608C Q48252785-18AAE732-B4C7-4F44-92D4-5B18D3FD6185 Q48361958-5C947527-5744-48CD-BC08-236C0A0E5DB2 Q53821043-C3D28FC2-773C-48FE-82A5-01F0B218F1C4 Q57597959-5AC263EA-383D-4161-8BE3-6AD24F9BBD1B Q58767947-2754FFA5-045E-4E3F-B4FB-2ED2B27E67B0

P2860

New therapeutic targets for mood disorders

http://www.wikidata.org/entity/Q28743068

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

New therapeutic targets for mood disorders

@ast

New therapeutic targets for mood disorders

@en

New therapeutic targets for mood disorders

@nl

type

label

New therapeutic targets for mood disorders

@ast

New therapeutic targets for mood disorders

@en

New therapeutic targets for mood disorders

@nl

prefLabel

New therapeutic targets for mood disorders

@ast

New therapeutic targets for mood disorders

@en

New therapeutic targets for mood disorders

@nl

P1433

Q28743068-85A6879E-6A89-458F-83AC-3828E1CDA6A9

P1476

Q28743068-9FFDC6AD-2913-48F5-8831-9C6B6C49D343

P2093

Q28743068-383B114C-589C-4F23-A997-D16B51D5FCA6

Q28743068-48AFB0AB-2CAC-4958-9BDB-7CB57F4F8DFE

Q28743068-4B507666-C33A-4DC4-A761-F0FD95E88DC5

Q28743068-5A5A56D4-3365-4145-B699-495397493F94

Q28743068-6E13072B-6162-457A-A732-D341111A096B

Q28743068-9051B8D7-5996-42C8-8BE0-11D6E6F273AC

Q28743068-960CF2DC-891A-466D-AC80-417D2CFCF5E5

Q28743068-FD64DD29-EA2A-478B-9D2A-CC6B3D43FCDC

P275

Q28743068-48ED0EEB-62D5-4D05-9CF4-F103A8815D4E

P2860

Q28743068-0985726D-B2F3-48E4-BD13-48D63E2C03E1

Q28743068-10578C14-579B-4637-B9B1-127D789E0684

Q28743068-12510938-8B3B-4D11-B548-12A1BA58C4F7

Q28743068-1C8D1EEF-546B-4BE6-B4C9-0F58EB8A5756

Q28743068-1D6FBFBD-3794-415F-BB0A-C7EF37A396D5

Q28743068-1E763969-C4B4-4BB0-8580-FF304BAF4CDF

Q28743068-216F47EE-478A-4C93-AFEE-6A2DAB274AE0

Q28743068-23CDA02E-9B01-4A80-8090-25485A9641F3

Q28743068-257F888B-688E-4AA2-8CBC-0803B7152C9B

Q28743068-285A7B5B-E52F-4D97-A294-40219A639C09

P304

Q28743068-7E86D2EA-AB3B-431B-A503-3C62D134A178

P31

Q28743068-0FD70054-26A6-4F91-B943-F86719F4692C

Q28743068-B5F52717-8C86-4C8F-B368-A5A3BFFDCCDA

P356

Q28743068-EC74E92B-C504-44F8-83D9-B0A9260673FF

P407

Q28743068-D66EFFF5-8890-468F-9B8E-132286BF6AAF

P478

Q28743068-B33CA0E8-E023-44BF-A949-A64A8532A3F9

P50

Q28743068-60D6B608-14D4-41C5-BA58-78A3BC607B09

P5008

Q28743068-3C61396A-BACE-47B4-B1D1-2FF940622E1E

P577

Q28743068-124A9AC4-AEC2-41D4-8559-3720366D55A2

P5875

Q28743068-05DCA039-CE79-440A-92E7-0A9A63CB35C0

P698

Q28743068-DA671AF0-DC5D-4D08-8CD8-3FEB7B2A4C67

P921

Q28743068-490BECA1-FF71-4639-9279-E9CC04B71FF4

Q28743068-55C5A6BC-3461-4DE8-9D9E-5E2FDAE3A0C2

P932

Q28743068-61140827-3E56-4DA5-BBE7-3E4F0DDBD1E9

P356

P1433

The Scientific World Journal

P1476

New therapeutic targets for mood disorders

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

Cristina Wheeler-Castillo

http://www.w3.org/2001/XMLSchema#string

David Latov

http://www.w3.org/2001/XMLSchema#string

Giacomo Salvadore

http://www.w3.org/2001/XMLSchema#string

Ioline D Henter

http://www.w3.org/2001/XMLSchema#string

Jacqueline Baumann

http://www.w3.org/2001/XMLSchema#string

Lobna Ibrahim

http://www.w3.org/2001/XMLSchema#string

Nancy DiazGranados

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Glycogen synthase kinase 3: more than a namesake

A molecular mechanism for the effect of lithium on development

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

Epigenetic programming by maternal behavior

5-HT2A and 5-HT2C receptors and their atypical regulation properties

Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data

Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models

P304

713-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1100/TSW.2010.65

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo Machado-Vieira

P5008

P577

2010-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43343603

http://www.w3.org/2001/XMLSchema#string

P698

20419280

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

3035047

http://www.w3.org/2001/XMLSchema#string